Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Irritable Bowel Syndrome Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Irritable Bowel Syndrome Drugsmarket, defines the market attractiveness level of Irritable Bowel Syndrome Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Irritable Bowel Syndrome Drugs industry, describes the types of Irritable Bowel Syndrome Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Irritable Bowel Syndrome Drugs market and the development prospects and opportunities of Irritable Bowel Syndrome Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Irritable Bowel Syndrome Drugs market in Chapter 13.
By Player:
Janssen
Dainippon Sumitomo Pharma
Tioga Pharmaceuticals
Ono Pharmaceutical
AstraZeneca
Astellas Pharma
GlaxoSmithKline
Takeda Pharmaceutical
Actavis
Abbott
Bayer
Drais Pharmaceuticals
Novartis
Nestle
Pfizer
Yuhan
By Type:
Type 1
Type 2
Type 3
By End-User:
Application 1
Application 2
Application 3
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Irritable Bowel Syndrome Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Irritable Bowel Syndrome Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Irritable Bowel Syndrome Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Irritable Bowel Syndrome Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Irritable Bowel Syndrome Drugs Market Analysis and Outlook to 2022
-
7.1 Global Irritable Bowel Syndrome Drugs Consumption (2017-2022)
-
7.2 United States Irritable Bowel Syndrome Drugs Consumption (2017-2022)
-
7.3 Europe Irritable Bowel Syndrome Drugs Consumption (2017-2022)
-
7.4 China Irritable Bowel Syndrome Drugs Consumption (2017-2022)
-
7.5 Japan Irritable Bowel Syndrome Drugs Consumption (2017-2022)
-
7.6 India Irritable Bowel Syndrome Drugs Consumption (2017-2022)
-
7.7 South Korea Irritable Bowel Syndrome Drugs Consumption (2017-2022)
8 Region and Country-wise Irritable Bowel Syndrome Drugs Market Analysis and Outlook to 2028
-
8.1 Global Irritable Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
8.2 United States Irritable Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Irritable Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
8.4 China Irritable Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Irritable Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
8.6 India Irritable Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Irritable Bowel Syndrome Drugs Consumption Forecast (2022-2028)
9 Global Irritable Bowel Syndrome Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Irritable Bowel Syndrome Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Type 1 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Type 2 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Type 3 Consumption and Growth Rate (2017-2022)
-
9.2 Global Irritable Bowel Syndrome Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Application 1 Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Application 2 Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Application 3 Consumption and Growth Rate (2017-2022)
10 Global Irritable Bowel Syndrome Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Irritable Bowel Syndrome Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Type 1 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Type 3 Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Irritable Bowel Syndrome Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Application 1 Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Application 2 Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Application 3 Consumption Forecast and Growth Rate (2022-2028)
11 Global Irritable Bowel Syndrome Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Irritable Bowel Syndrome Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Irritable Bowel Syndrome Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Irritable Bowel Syndrome Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Irritable Bowel Syndrome Drugs Market Competitive Analysis
-
14.1 Janssen
-
14.1.1 Janssen Company Details
-
14.1.2 Janssen Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Janssen Irritable Bowel Syndrome Drugs Product and Service
-
14.2 Dainippon Sumitomo Pharma
-
14.2.1 Dainippon Sumitomo Pharma Company Details
-
14.2.2 Dainippon Sumitomo Pharma Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Dainippon Sumitomo Pharma Irritable Bowel Syndrome Drugs Product and Service
-
14.3 Tioga Pharmaceuticals
-
14.3.1 Tioga Pharmaceuticals Company Details
-
14.3.2 Tioga Pharmaceuticals Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Tioga Pharmaceuticals Irritable Bowel Syndrome Drugs Product and Service
-
14.4 Ono Pharmaceutical
-
14.4.1 Ono Pharmaceutical Company Details
-
14.4.2 Ono Pharmaceutical Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Ono Pharmaceutical Irritable Bowel Syndrome Drugs Product and Service
-
14.5 AstraZeneca
-
14.5.1 AstraZeneca Company Details
-
14.5.2 AstraZeneca Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AstraZeneca Irritable Bowel Syndrome Drugs Product and Service
-
14.6 Astellas Pharma
-
14.6.1 Astellas Pharma Company Details
-
14.6.2 Astellas Pharma Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Astellas Pharma Irritable Bowel Syndrome Drugs Product and Service
-
14.7 GlaxoSmithKline
-
14.7.1 GlaxoSmithKline Company Details
-
14.7.2 GlaxoSmithKline Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 GlaxoSmithKline Irritable Bowel Syndrome Drugs Product and Service
-
14.8 Takeda Pharmaceutical
-
14.8.1 Takeda Pharmaceutical Company Details
-
14.8.2 Takeda Pharmaceutical Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Takeda Pharmaceutical Irritable Bowel Syndrome Drugs Product and Service
-
14.9 Actavis
-
14.9.1 Actavis Company Details
-
14.9.2 Actavis Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Actavis Irritable Bowel Syndrome Drugs Product and Service
-
14.10 Abbott
-
14.10.1 Abbott Company Details
-
14.10.2 Abbott Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Abbott Irritable Bowel Syndrome Drugs Product and Service
-
14.11 Bayer
-
14.11.1 Bayer Company Details
-
14.11.2 Bayer Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Bayer Irritable Bowel Syndrome Drugs Product and Service
-
14.12 Drais Pharmaceuticals
-
14.12.1 Drais Pharmaceuticals Company Details
-
14.12.2 Drais Pharmaceuticals Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Drais Pharmaceuticals Irritable Bowel Syndrome Drugs Product and Service
-
14.13 Novartis
-
14.13.1 Novartis Company Details
-
14.13.2 Novartis Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Novartis Irritable Bowel Syndrome Drugs Product and Service
-
14.14 Nestle
-
14.14.1 Nestle Company Details
-
14.14.2 Nestle Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Nestle Irritable Bowel Syndrome Drugs Product and Service
-
14.15 Pfizer
-
14.15.1 Pfizer Company Details
-
14.15.2 Pfizer Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Pfizer Irritable Bowel Syndrome Drugs Product and Service
-
14.16 Yuhan
-
14.16.1 Yuhan Company Details
-
14.16.2 Yuhan Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Yuhan Irritable Bowel Syndrome Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Irritable Bowel Syndrome Drugs
-
Figure Irritable Bowel Syndrome Drugs Picture
-
Table Global Irritable Bowel Syndrome Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Irritable Bowel Syndrome Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Irritable Bowel Syndrome Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Irritable Bowel Syndrome Drugs Consumption by Country (2017-2022)
-
Figure United States Irritable Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Irritable Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Irritable Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Irritable Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Irritable Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Irritable Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Irritable Bowel Syndrome Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Irritable Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Irritable Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Irritable Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Irritable Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Irritable Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Irritable Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 1 Consumption and Growth Rate (2017-2022)
-
Figure Global Type 2 Consumption and Growth Rate (2017-2022)
-
Figure Global Type 3 Consumption and Growth Rate (2017-2022)
-
Figure Global Application 1 Consumption and Growth Rate (2017-2022)
-
Figure Global Application 2 Consumption and Growth Rate (2017-2022)
-
Figure Global Application 3 Consumption and Growth Rate (2017-2022)
-
Figure Global Type 1 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 3 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Application 1 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Application 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Application 3 Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Irritable Bowel Syndrome Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Irritable Bowel Syndrome Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Janssen (Foundation Year, Company Profile and etc.)
-
Table Janssen Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Irritable Bowel Syndrome Drugs Product and Service
-
Table Dainippon Sumitomo Pharma (Foundation Year, Company Profile and etc.)
-
Table Dainippon Sumitomo Pharma Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dainippon Sumitomo Pharma Irritable Bowel Syndrome Drugs Product and Service
-
Table Tioga Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Tioga Pharmaceuticals Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tioga Pharmaceuticals Irritable Bowel Syndrome Drugs Product and Service
-
Table Ono Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Ono Pharmaceutical Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ono Pharmaceutical Irritable Bowel Syndrome Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Irritable Bowel Syndrome Drugs Product and Service
-
Table Astellas Pharma (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Irritable Bowel Syndrome Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Irritable Bowel Syndrome Drugs Product and Service
-
Table Takeda Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Irritable Bowel Syndrome Drugs Product and Service
-
Table Actavis (Foundation Year, Company Profile and etc.)
-
Table Actavis Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actavis Irritable Bowel Syndrome Drugs Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Irritable Bowel Syndrome Drugs Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Irritable Bowel Syndrome Drugs Product and Service
-
Table Drais Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Drais Pharmaceuticals Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Drais Pharmaceuticals Irritable Bowel Syndrome Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Irritable Bowel Syndrome Drugs Product and Service
-
Table Nestle (Foundation Year, Company Profile and etc.)
-
Table Nestle Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nestle Irritable Bowel Syndrome Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Irritable Bowel Syndrome Drugs Product and Service
-
Table Yuhan (Foundation Year, Company Profile and etc.)
-
Table Yuhan Irritable Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Yuhan Irritable Bowel Syndrome Drugs Product and Service
-
